Livia Basile

868 citations
47 papers · 697 indexed · h-index 16
Topics
Receptor Mechanisms and Signaling (6 papers)Synthesis and biological activity (5 papers)Neuropeptides and Animal Physiology (4 papers)

In The Last Decade

Livia Basile

47 papers receiving 681 citations

Peers

Livia Basile
Comparison fields: 5 of 100
  • Molecular Biology 316
  • Organic Chemistry 210
  • Pharmacology 145
  • Biomaterials 99
  • Computational Theory and Mathematics 90
Replace İpek Baysal with:
İpek Baysal Türkiye
Zuzana Bednáriková Slovakia
Anne Sophie Voisin‐Chiret France
Aurélie Malzert‐Fréon France
Francesco Attanasio Italy
Ludy van Beijsterveldt Belgium
Meenakshi Dhanawat India
Xiaojun Gou China
Saima Nusrat India
Simon Žakelj Slovenia
Livia Basile relative to İpek Baysal Türkiye İpek Baysal's profile →
Citations per field
00.5×1.7×
İpek Baysal · 1×
Citations per year

Countries citing papers authored by Livia Basile

Since Specialization
Citations

This map shows the geographic impact of Livia Basile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Livia Basile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Livia Basile more than expected).

Fields of papers citing papers by Livia Basile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Livia Basile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Livia Basile. The network helps show where Livia Basile may publish in the future.

Co-authorship network of co-authors of Livia Basile

This figure shows the co-authorship network connecting the top 25 collaborators of Livia Basile. A scholar is included among the top collaborators of Livia Basile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Livia Basile. Livia Basile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 3
5 7
6 3
7 9
8 15
9 1
10 32
11 22
12 4
13 11
14 17
15 2
16 63
17 29
18 96
19 17
20 8

About Livia Basile

Livia Basile is a scholar working on Molecular Medicine, Pharmaceutical Science and Pharmacology, having authored 47 papers that have together received 697 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Synthesis and biological activity (5 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Pharmacology (145 citations), Biomaterials (99 citations) and Organic Chemistry (210 citations). Livia Basile has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Rosario Pignatello, Salvatore Guccione, Giovanni Puglisi, Catherine Passirani, Claudia Carbone, Teresa Musumeci, Matteo Pappalardo, Fatih Sönmez, Belma Zengin Kurt and Işıl Gazioğlu. Their work appears in journals such as PLoS ONE, Molecules and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026